Regarding the latter point, there is preliminary evidence that a continuous measure of neuronal α-synuclein SAA (i.e., kinetic parameters) is associated with cognitive performance in PD(37), so future research can examine if there is a correlation between this measure and cognitive performance in Stage 2 NSD. The gene discussed is SNCA; the disease is Parkinson disease.